Sisram MedicalSRAMF 60 EV-to-FCF is 20.28 as of Jun. 27, 2026, which is 121% above its 10-year median of 9.16. GuruFocus rates SRAMF with a GF Score™ of 60/100 and a GF Value™ of $0.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 421 Medical Devices & Instruments companies, Sisram Medical ranks better than 53.44% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sisram Medical's Enterprise Value is $138.3 Mil.
Sisram Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $6.8 Mil. Therefore, Sisram Medical's EV-to-FCF for today is 20.28.
The historical rank and industry rank for Sisram Medical's EV-to-FCF or its related term are showing as below:
SRAMF'
s EV-to-FCF Range Over the Past 10 Years
Min: -22.05 Med: 9.16 Max: 96.7
Current: 20.62
During the past 12 years, the highest EV-to-FCF of Sisram Medical was 96.70. The lowest was -22.05. And the median was 9.16.
SRAMF's EV-to-FCF is ranked better than 53.44% of 421
companies
in the Medical Devices & Instruments industry
Industry Median: 22.82
vs SRAMF: 20.62
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sisram Medical (OTCPK:SRAMF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sisram Medical's PE Ratio (TTM) for today is calculated as:
Sisram Medical's share price for today is $0.43835.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.041.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sisram Medical EV-to-FCF Related Terms
Sisram Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Sisram Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sisram Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sisram Medical's EV-to-FCF falls into.
Sisram Medical's current Enterprise Value is $138.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $6.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical (SRAMF) has a EV-to-FCF of 20.28 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sisram Medical and its competitors. This is 121% above median its historical median of 9.16. According to the industry distribution chart, Sisram Medical ranks #196 out of 421 companies in the Medical Devices & Instruments industry, placing it in the top 46.6%.
Is Sisram Medical's EV-to-FCF too high?
Sisram Medical's current EV-to-FCF of 20.28 is 121% above median its 10-year median of 9.16. The Medical Devices & Instruments industry median EV-to-FCF is 22.82. Sisram Medical's value of 20.28 is 11.1% below this industry median. Based on the distribution chart, Sisram Medical ranks #196 out of 421 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sisram Medical has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #196 out of 421 companies for EV-to-FCF. This puts Sisram Medical in the upper half of its industry. The industry median EV-to-FCF is 22.82. Sisram Medical's value of 20.28 is 11.1% below this benchmark. While the company's 10-year median is 9.16 vs. the industry median of 22.82, Sisram Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.82, based on 421 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sisram Medical's current EV-to-FCF of 20.28 is 11.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sisram Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sisram Medical's current EV-to-FCF is 20.28, which is 121% above median its own 10-year median of 9.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.95, compared to a current price of $0.44 — trading 53.9% below its estimated fair value. The current EV-to-FCF is 20.28, which is 121% above median its 10-year median of 9.16 and 11.1% below the Medical Devices & Instruments industry median of 22.82. Sisram Medical's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current EV-to-FCF is 20.28 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sisram Medical (SRAMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued.
The current stock price of $0.44 is trading 53.9% below its estimated GF Value™ of $0.95.
GuruFocus considers Sisram Medical to be Significantly Undervalued.
Key valuation signals for SRAMF:
EV-to-FCF: 20.28 (121% above median its 10-year median of 9.16)
GF Value™: $0.95 vs. price of $0.44 (53.9% below fair value)
Industry Position: 11.1% below the Medical Devices & Instruments median (#196 of 421)
No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
60GF Score
Get the complete analysis for SRAMF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRAMF has been successfully added to your 
